ReviewPharmaceuticals (Basel, Switzerland)2024
Biosimilars in the Era of Artificial Intelligence-International Regulations and the Use in Oncological Treatments.
Tomas Gabriel Bas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it